Novartis AG
SIX:NOVN

Watchlist Manager
Novartis AG Logo
Novartis AG
SIX:NOVN
Watchlist
Price: 91.11 CHF -1% Market Closed
Updated: May 29, 2024

Balance Sheet

Balance Sheet Decomposition
Novartis AG

Current Assets 26.4B
Cash & Short-Term Investments 9.6B
Receivables 8.3B
Other Current Assets 8.6B
Non-Current Assets 67.9B
Long-Term Investments 2.6B
PP&E 10.5B
Intangibles 49.3B
Other Non-Current Assets 5.4B
Current Liabilities 29.3B
Accounts Payable 4.1B
Other Current Liabilities 25.2B
Non-Current Liabilities 25.4B
Long-Term Debt 18.7B
Other Non-Current Liabilities 6.7B

Balance Sheet
Novartis AG

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
13 023
4 674
7 007
8 860
13 271
11 112
9 658
12 407
7 517
13 393
Cash
3 607
3 074
1 912
2 970
3 121
3 247
3 750
3 396
2 877
3 207
Cash Equivalents
9 416
1 600
5 095
5 890
10 150
7 865
5 908
9 011
4 640
10 186
Short-Term Investments
480
628
539
487
2 447
122
1 635
15 706
11 209
680
Total Receivables
10 258
10 553
10 208
11 101
11 036
10 337
10 036
9 621
9 894
9 376
Accounts Receivables
8 278
8 182
8 203
8 601
8 739
8 301
8 217
8 005
8 066
7 107
Other Receivables
1 980
2 371
2 005
2 500
2 297
2 036
1 819
1 616
1 828
2 269
Inventory
6 093
6 226
6 255
6 867
6 956
5 982
7 131
6 666
7 175
5 913
Other Current Assets
7 707
764
922
893
1 853
1 951
1 213
1 318
1 115
1 119
Total Current Assets
37 561
22 845
24 931
28 208
35 563
29 504
29 673
45 718
36 910
30 481
PP&E Net
15 983
15 982
15 641
16 464
15 696
13 746
13 939
13 106
12 195
10 924
PP&E Gross
15 983
15 982
15 641
16 464
15 696
13 746
13 939
13 106
12 195
10 924
Accumulated Depreciation
15 445
15 466
15 655
17 546
18 332
14 930
15 955
15 602
14 109
11 879
Intangible Assets
23 832
34 217
31 340
29 997
38 719
28 787
36 809
34 182
31 644
26 879
Goodwill
29 311
31 174
30 980
31 750
35 294
26 524
29 999
29 595
29 301
23 341
Note Receivable
712
1 203
1 100
968
908
624
922
973
948
985
Long-Term Investments
9 440
16 577
15 400
16 645
9 789
10 538
11 611
2 268
1 606
1 827
Other Long-Term Assets
8 548
9 558
10 732
9 047
9 594
8 647
4 825
5 953
4 849
5 508
Other Assets
29 311
31 174
30 980
31 750
35 294
26 524
29 999
29 595
29 301
23 341
Total Assets
125 387
N/A
131 556
+5%
130 124
-1%
133 079
+2%
145 563
+9%
118 370
-19%
127 778
+8%
131 795
+3%
117 453
-11%
99 945
-15%
Liabilities
Accounts Payable
5 419
5 668
4 873
5 169
5 556
5 424
5 403
5 553
5 146
4 926
Accrued Liabilities
4 402
4 366
4 169
4 811
5 105
5 058
5 336
5 100
5 334
5 154
Short-Term Debt
3 571
3 915
5 611
4 842
6 430
4 844
7 319
3 606
3 635
3 893
Current Portion of Long-Term Debt
2 989
1 659
178
359
3 190
2 248
2 558
2 896
2 492
2 421
Other Current Liabilities
10 592
8 100
7 378
8 222
9 326
10 690
12 443
13 053
12 049
9 996
Total Current Liabilities
26 973
23 708
22 209
23 403
29 607
28 264
33 059
30 208
28 656
26 390
Long-Term Debt
13 799
16 327
17 897
23 224
22 470
22 056
27 978
24 523
21 782
20 034
Deferred Income Tax
6 099
6 355
6 657
5 168
7 475
5 867
3 141
3 070
2 686
2 248
Minority Interest
78
76
59
59
78
77
68
167
81
83
Other Liabilities
7 672
8 044
8 470
7 057
7 319
6 632
6 934
6 172
4 906
4 523
Total Liabilities
54 621
N/A
54 510
0%
55 292
+1%
58 911
+7%
66 949
+14%
62 896
-6%
71 180
+13%
64 140
-10%
58 111
-9%
53 278
-8%
Equity
Common Stock
1 001
991
972
969
944
936
913
901
890
825
Retained Earnings
69 868
80 379
81 148
77 639
82 191
59 274
57 157
70 989
63 540
49 649
Unrealized Security Profit/Loss
0
461
348
386
206
0
0
0
198
158
Treasury Stock
103
101
76
100
69
80
53
48
92
41
Other Equity
0
4 684
7 560
4 726
4 658
4 656
1 419
4 187
4 798
3 608
Total Equity
70 766
N/A
77 046
+9%
74 832
-3%
74 168
-1%
78 614
+6%
55 474
-29%
56 598
+2%
67 655
+20%
59 342
-12%
46 667
-21%
Total Liabilities & Equity
125 387
N/A
131 556
+5%
130 124
-1%
133 079
+2%
145 563
+9%
118 370
-19%
127 778
+8%
131 795
+3%
117 453
-11%
99 945
-15%
Shares Outstanding
Common Shares Outstanding
2 399
2 374
2 374
2 317
2 311
2 265
2 257
2 235
2 120
2 044

See Also

Discover More